(Q45887428)

17 December 2017

review article

1 reference

title

Can haemophilic arthropathy be prevented? (English)

1 reference

17 December 2017

0 references

Ljung RC

1

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

17 December 2017

British Journal of Haematology

published in

1 reference

17 December 2017

volume

101

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

215-219

1 reference

17 December 2017

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Hemophilia prophylaxis with factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

The impact of prophyactic treatment on children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Use of central venous catheters in children with severe congenital coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Results of secondary prophylaxis in children with severe hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Haemophilia prophylaxis in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Arthropathy in children with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00707.X

10.1046/J.1365-2141.1998.00707.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

9609513

1 reference

17 December 2017